Eskova et al., 2014 - Google Patents
An RNAi screen identifies KIF15 as a novel regulator of the endocytic trafficking of integrinEskova et al., 2014
View HTML- Document ID
- 228008921234273199
- Author
- Eskova A
- Knapp B
- Matelska D
- Reusing S
- Arjonen A
- Lisauskas T
- Pepperkok R
- Russell R
- Eils R
- Ivaska J
- Kaderali L
- Erfle H
- Starkuviene V
- Publication year
- Publication venue
- Journal of cell science
External Links
Snippet
ABSTRACT α2β1 integrin is one of the most important collagen-binding receptors, and it has been implicated in numerous thrombotic and immune diseases. α2β1 integrin is a potent tumour suppressor, and its downregulation is associated with increased metastasis and …
- 101700023135 KIF15 0 title abstract description 95
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Eskova et al. | An RNAi screen identifies KIF15 as a novel regulator of the endocytic trafficking of integrin | |
| Neill et al. | EphA2 is a functional receptor for the growth factor progranulin | |
| Georgiadou et al. | AMPK negatively regulates tensin-dependent integrin activity | |
| Steinberg et al. | SNX17 protects integrins from degradation by sorting between lysosomal and recycling pathways | |
| Song et al. | Pou5f1-dependent EGF expression controls E-cadherin endocytosis, cell adhesion, and zebrafish epiboly movements | |
| Solis et al. | Golgi-resident Gαo promotes protrusive membrane dynamics | |
| Zoncu et al. | A phosphoinositide switch controls the maturation and signaling properties of APPL endosomes | |
| Hotulainen et al. | Actin-depolymerizing factor and cofilin-1 play overlapping roles in promoting rapid F-actin depolymerization in mammalian nonmuscle cells | |
| Lee et al. | Targeted manipulation of the sortilin–progranulin axis rescues progranulin haploinsufficiency | |
| Astro et al. | Liprin-α1, ERC1 and LL5 define polarized and dynamic structures that are implicated in cell migration | |
| Fu et al. | LC3 binding to the scaffolding protein JIP1 regulates processive dynein-driven transport of autophagosomes | |
| Farhan et al. | MAPK signaling to the early secretory pathway revealed by kinase/phosphatase functional screening | |
| Seaman et al. | Inhibition of TBC1D5 activates Rab7a and can enhance the function of the retromer cargo-selective complex | |
| Jastrzębski et al. | Multiple routes of endocytic internalization of PDGFRβ contribute to PDGF-induced STAT3 signaling | |
| Gupta et al. | Analysis of endocytic pathways in Drosophila cells reveals a conserved role for GBF1 in internalization via GEECs | |
| Marchesin et al. | ARF6 promotes the formation of Rac1 and WAVE-dependent ventral F-actin rosettes in breast cancer cells in response to epidermal growth factor | |
| Scharaw et al. | The endosomal transcriptional regulator RNF11 integrates degradation and transport of EGFR | |
| Hale et al. | SMRT analysis of MTOC and nuclear positioning reveals the role of EB1 and LIC1 in single-cell polarization | |
| Francis et al. | Endocytic membrane turnover at the leading edge is driven by a transient interaction between Cdc42 and GRAF1 | |
| Ruppersburg et al. | The Ca2+-activated Cl− channel ANO1/TMEM16A regulates primary ciliogenesis | |
| Wei et al. | Smurf1 inhibits integrin activation by controlling Kindlin-2 ubiquitination and degradation | |
| Loskutov et al. | NEDD9/Arf6-dependent endocytic trafficking of matrix metalloproteinase 14: a novel mechanism for blocking mesenchymal cell invasion and metastasis of breast cancer | |
| Valdivia et al. | Regulation of circular dorsal ruffles, macropinocytosis, and cell migration by RhoG and its exchange factor, Trio | |
| Chen et al. | CDK1–cyclin-B1-induced kindlin degradation drives focal adhesion disassembly at mitotic entry | |
| Hou et al. | XAB2 functions in mitotic cell cycle progression via transcriptional regulation of CENPE |